ANGO vs CCEP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANGO is a Hold and CCEP is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANGO’s FA Score shows that 0 FA rating(s) are green whileCCEP’s FA Score has 2 green FA rating(s).
- ANGO’s FA Score: 0 green, 5 red.
- CCEP’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANGO’s TA Score shows that 3 TA indicator(s) are bullish while CCEP’s TA Score has 5 bullish TA indicator(s).
- ANGO’s TA Score: 3 bullish, 5 bearish.
- CCEP’s TA Score: 5 bullish, 4 bearish.
Price Growth
ANGO (@Medical Specialties) experienced а -2.82% price change this week, while CCEP (@Beverages: Non-Alcoholic) price change was +2.71% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +2.55%. For the same industry, the average monthly price growth was -8.97%, and the average quarterly price growth was -4.20%.
The average weekly price growth across all stocks in the @Beverages: Non-Alcoholic industry was +1.18%. For the same industry, the average monthly price growth was +1.10%, and the average quarterly price growth was +8.90%.
Reported Earning Dates
ANGO is expected to report earnings on Jul 09, 2025.
CCEP is expected to report earnings on Aug 06, 2025.
Industries' Descriptions
@Medical Specialties (+2.55% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Beverages: Non-Alcoholic (+1.18% weekly)Non-alcoholic drinks include traces of alcohol or low alcohol content or without alcohol or alcohol removed. Functional Beverages, Carbonated Soft Drinks (CSDs), Sports Drinks, Fruit Beverages, and Bottled Water are some common types of non-alcoholic beverages. The largest segment in this market is soft drinks (think Pepsi and Coke). Many established companies in this space have also been stepping up production of low to zero-calorie varieties in recent years, to cater to a rising number of health-conscious consumers. Coca-Cola Company, Pepsico Inc, Keurig Dr Pepper Inc. and Monster Beverage Corporation are some major non-alcoholic beverage makers.
| ANGO | CCEP | ANGO / CCEP | |
| Capitalization | 234M | 32.7B | 1% |
| EBITDA | -28.49M | 3.16B | -1% |
| Gain YTD | 1.528 | 18.097 | 8% |
| P/E Ratio | 44.84 | 17.67 | 254% |
| Revenue | 330M | 18.3B | 2% |
| Total Cash | 60.9M | 1.99B | 3% |
| Total Debt | 4.73M | 11.4B | 0% |
ANGO | CCEP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 71 Overvalued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 7 | |
SMR RATING 1..100 | 92 | 96 | |
PRICE GROWTH RATING 1..100 | 48 | 41 | |
P/E GROWTH RATING 1..100 | 48 | 14 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CCEP's Valuation (41) in the null industry is in the same range as ANGO (71) in the Medical Specialties industry. This means that CCEP’s stock grew similarly to ANGO’s over the last 12 months.
CCEP's Profit vs Risk Rating (7) in the null industry is significantly better than the same rating for ANGO (100) in the Medical Specialties industry. This means that CCEP’s stock grew significantly faster than ANGO’s over the last 12 months.
ANGO's SMR Rating (92) in the Medical Specialties industry is in the same range as CCEP (96) in the null industry. This means that ANGO’s stock grew similarly to CCEP’s over the last 12 months.
CCEP's Price Growth Rating (41) in the null industry is in the same range as ANGO (48) in the Medical Specialties industry. This means that CCEP’s stock grew similarly to ANGO’s over the last 12 months.
CCEP's P/E Growth Rating (14) in the null industry is somewhat better than the same rating for ANGO (48) in the Medical Specialties industry. This means that CCEP’s stock grew somewhat faster than ANGO’s over the last 12 months.
| ANGO | CCEP | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 31% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 45% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 52% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 59% |
| TrendWeek ODDS (%) | 2 days ago 74% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 58% |
| Advances ODDS (%) | 10 days ago 78% | 9 days ago 58% |
| Declines ODDS (%) | 8 days ago 72% | 16 days ago 43% |
| BollingerBands ODDS (%) | 2 days ago 82% | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 70% | 2 days ago 58% |
ANGO and
Correlation & Price change
A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with STRRP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then STRRP could also see price increases.
| Ticker / NAME | Correlation To ANGO | 1D Price Change % | ||
|---|---|---|---|---|
| ANGO | 100% | +0.54% | ||
| STRRP - ANGO | 48% Loosely correlated | +7.90% | ||
| MXCT - ANGO | 38% Loosely correlated | +6.23% | ||
| QDEL - ANGO | 36% Loosely correlated | -0.41% | ||
| NVST - ANGO | 35% Loosely correlated | +2.02% | ||
| ICUI - ANGO | 35% Loosely correlated | -4.42% | ||
More | ||||
CCEP and
Correlation & Price change
A.I.dvisor indicates that over the last year, CCEP has been loosely correlated with KDP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CCEP jumps, then KDP could also see price increases.
| Ticker / NAME | Correlation To CCEP | 1D Price Change % | ||
|---|---|---|---|---|
| CCEP | 100% | +2.53% | ||
| KDP - CCEP | 55% Loosely correlated | +0.48% | ||
| KO - CCEP | 53% Loosely correlated | +1.55% | ||
| MNST - CCEP | 41% Loosely correlated | +2.19% | ||
| COKE - CCEP | 39% Loosely correlated | +0.67% | ||
| KOF - CCEP | 37% Loosely correlated | +1.27% | ||
More | ||||